Franco-Indian Pharmaceuticals Private Limited v. Benatton Pharmaceutical Private Limited

1/2 32-IA-6676-2025 (OS).DOC

IN THE HIGH COURT OF JUDICATURE AT BOMBAY

ORDINARY ORIGINAL CIVIL JURISDICTION INTERIM APPLICATION NO. 6676 OF 2025 IN COMMERCIAL IP SUIT NO. 193 OF 2023 Franco-indian Pharmaceuticals Private Limited ...Applicant/Plaintiff

Versus

Benatton Pharmaceutical Private Limited ...Defendant WITH INTERIM APPLICATION NO. 6775 OF 2025 IN INTERIM APPLICATION NO. 6676 OF 2025 WITH COURT RECEIVER REPORT NO. 223 OF 2023 IN COMMERCIAL IP SUIT NO. 193 OF 2023 WITH COMMERCIAL IP SUIT NO. 285 OF 2023 WITH INTERIM APPLICATION (L) NO. 26960 OF 2023 WITH INTERIM APPLICATION NO. 1678 OF 2025 WITH COURT RECEIVER REPORT NO. 244 OF 2023 WITH LEAVE PETITION (L) NO. 15830 OF 2023 WITH INTERIM APPLICATION NO. 6677 OF 2025 IN COMMERCIAL IP SUIT NO. 285 OF 2023 _______ Ms. Archita Gharat a/w Mr. Kiran Mehta i/b Mr. Kiran Mehta, for the Plaintiff in COMIP/193/2023.

Ms. Pooja Jain, for Defendant Nos. 1 & 2 in COMIP/193/2023. Vaibhav

2/2 32-IA-6676-2025 (OS).DOC Mr. Pravin Singh i/b Ashok Singh, for Defendant No.1 in COMIP/285/2023. Ms. Naina Poojary, Master (Adm.) office of the Court Receiver, present. _______ CORAM : ARIF S. DOCTOR, J.

th MARCH, 2026 DATE : 10 P.C.

1.

Today, learned counsel submit that the managements of the respective parties are negotiating a settlement.

2.

Ms. Gharat, learned counsel for the Plaintiff points out that Commercial IP Suit No. 285 of 2023 be de-tagged from Commercial IP Suit No.193 of 2023. 3.

The Registry is directed to accept the affidavit in reply to Interim Application (L) No. 26960 of 2023 as also the rejoinder in Interim Application No.6677 of 2025.

th March 2026.

4.

Stand over to 24 [ARIF S. DOCTOR, J.] Vaibhav